Research
Education
Solutions
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Oncology R&D group
Andreas Giannakou has not added Biography.
If you are Andreas Giannakou and would like to personalize this page please email our Author Liaison for assistance.
Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growth.
Oncotarget Feb, 2015 | Pubmed ID: 25671303
Purine Nucleotide Availability Regulates mTORC1 Activity through the Rheb GTPase.
Cell reports 06, 2017 | Pubmed ID: 28658616
Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture.
Proceedings of the National Academy of Sciences of the United States of America 12, 2018 | Pubmed ID: 30487219
Pfizer Worldwide Research and Development
Shuang Chen1,
Andreas Giannakou1,
Jonathon Golas1,
Kenneth G. Geles1
1Oncology R&D group, Pfizer Worldwide Research and Development
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Librarians
Access
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved
